广泛采用照相筛查后弱视诊疗趋势
这项回顾性队列研究分析了2015至2022年北加州大型多专科诊所集团中约3岁儿童的电子健康记录,比较照相筛查扩大前后视力筛查、转诊和弱视诊断率的变化。筛查率从2015年的5.7%升至2022年的72.1%,转诊率从17.0%升至2018年的23.6%,诊断率在2018年达峰值3.4%后于2022年降至1.4%。亚裔、黑人和西班牙裔患者较白人更少接受筛查,而亚裔和西班牙裔患者更可能被转诊和诊断。
要点
- 2015至2022年3岁儿童视力筛查率从5.7%升至72.1%,转诊率从17.0%升至2018年23.6%。
- 弱视诊断率2015年2.7%,2018年峰值3.4%,2022年降至1.4%。
- 亚裔、黑人和西班牙裔患者较白人筛查率更低,亚裔和西班牙裔转诊及诊断率更高。
核心结论
- 在这项研究中,照相筛查设备可及性增加与相对大型医疗系统中3岁儿童总体视力筛查率上升相关。
- 鉴于美国视力损害率预计将上升,需要额外的针对性干预措施来解决弱视诊疗中剩余的患者和临床医生层面的差异。
研究设计与样本
- 回顾性队列研究,使用2015至2022年北加州相对大型多专科集团诊所中约3岁(2.75-3.25岁)接受健康儿童照护访视患者的电子健康记录数据及关联的人口普查数据。
- 2015-2017年数据纳入23 246名至少1次健康儿童照护访视的3岁患者(11 206名[48.2%]女性),2018-2022年扩大后数据纳入34 281名患者(16 517名[48.2%]女性)。
- 数据提取与分析时间为2022年10月至2023年8月。
主要发现
- 筛查率从2015年的5.7%(424/7505)上升至2022年的72.1%(4578/6354)。
- 转诊率从2015年的17.0%(1279/7505)上升至2018年的23.6%(1836/7792)。
- 诊断率2015年为2.7%(200/7505),2018年达峰值3.4%(263/7792),2022年降至1.4%(88/6354)。
- 与白人患者相比,亚裔、黑人和西班牙裔患者接受筛查的可能性更低(亚裔:AOR 0.80,95%CI 0.72-0.88;黑人:AOR 0.71,95%CI 0.53-0.96;西班牙裔:AOR 0.88,95%CI 0.80-0.97)。
- 与白人患者相比,亚裔和西班牙裔患者更可能被转诊(亚裔:AOR 1.49,95%CI 1.36-1.62;西班牙裔:AOR 1.32,95%CI 1.18-1.48)和更可能被诊断(亚裔:AOR 1.29,95%CI 1.07-1.56;西班牙裔:AOR 1.67,95%CI 1.33-2.11)。
关键数值与推荐
- 2017年美国预防服务工作组推荐所有3至5岁儿童至少进行一次视力筛查以检测弱视。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Amblyopia can result in permanent vision loss if not properly treated before age 7 years. In 2017, the US Preventive Services Task Force recommended that vision screening should occur at least once in all children aged 3 to 5 years to detect amblyopia. OBJECTIVE: To understand trends and factors associated with screening, referral, or diagnosis of amblyopia before and after photoscreening expansion across a relatively large health care system in late 2017. DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective cohort study of electronic health record data from patients with a well child care visit at approximately age 3 years (ages 2.75-3.25 years) in a relatively large, multispecialty group practice in Northern California and linked census data between 2015 and 2022. Data were extracted and analyzed from October 2022 through August 2023. EXPOSURES: Patient sex, race and ethnicity, immunization records, previous well child care visits, and census-level median household income. MAIN OUTCOMES AND MEASURES: Vision screening, pediatric ophthalmology referral, or amblyopia diagnosis, compared using adjusted odds ratios (AORs). RESULTS: The study included 2015-2017 data from 23 246 patients aged 3 years with at least 1 well child care visit (11 206 [48.2%] female) compared with 2018-2022 postexpansion data from 34 281 patients (16 517 [48.2%] female). The screening rate increased from 5.7% (424 of 7505) in 2015 to 72.1% (4578 of 6354) in 2022. The referral rate increased from 17.0% (1279 of 7505) in 2015 to 23.6% (1836 of 7792) in 2018. The diagnosis rate was 2.7% (200 of 7505) in 2015, peaked at 3.4% (263 of 7792) in 2018, and decreased to 1.4% (88 of 6354) in 2022. Compared with White patients, patients who were Asian, Black, or Hispanic were less likely to be screened (Asian: AOR, 0.80; 95% CI, 0.72-0.88; Black: AOR, 0.71; 95% CI, 0.53-0.96; Hispanic: AOR, 0.88; 95% CI, 0.80-0.97). Compared with White patients, patients who were Asian or Hispanic were more likely to be referred (Asian: AOR, 1.49; 95% CI, 1.36-1.62; Hispanic: AOR, 1.32; 95% CI, 1.18-1.48) and were more likely to be diagnosed (Asian: AOR, 1.29; 95% CI, 1.07-1.56; Hispanic: AOR, 1.67; 95% CI, 1.33-2.11). CONCLUSIONS AND RELEVANCE: In this study, increased availability of photoscreeners was associated with an increase in overall rates of vision screening for children aged 3 years in a relatively large health care system. Given that US rates of visual impairment are predicted to increase, additional targeted interventions would be needed to address remaining disparities in amblyopia care along patient- and clinician-level factors.
引用
- Stults CD, Liang SY, Wilcox J, et al. Amblyopia Care Trends Following Widespread Photoscreener Adoption. JAMA Ophthalmol. 2024. PMID: 38300546. doi:10.1001/jamaophthalmol.2023.6434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。